An independent healthcare market research firm states that sales in the drug testing market increased by 4.3% from 2011 to 2013, and are projected to exceed $3 billion by 2015.
The emergence of new drugs of abuse, as well as steady demand for testing services in workplaces, sports and government, were cited as drivers of the upward trend in spending, according to New York-based Kalorama Information's report Drugs of Abuse Testing Markets.
The report states that sales in the testing market reached $2.8 billion in 2013. The text highlights the challenges associated with technology's staying ahead of new forms of illicit drugs, such as synthetic cannabinoids.
The report includes market breakouts by world region, and it profiles more than 30 companies in the industry.